Trial intelligence / Profile preview

Open-label multicenter study of topical heparinoid (M118102) in asteatosis

jRCT1080223223Phase 3Completed

Sponsor
Maruho Co., Ltd.
Start
May 2016
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of mucopolysaccharide polysulphate in Asteatosis, sponsored by Maruho Co., Ltd. Primary endpoints: Efficacy maintenance after switch from soft ointment to M118102 and Safety of M118102. Started May 2016; status: completed.

02

Drugs

mucopolysaccharide polysulphate
03

Conditions

Asteatosis

Beyond the preview

Go deeper on jRCT1080223223.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1080223223.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call